Simplex Trading, LLC Silence Therapeutics PLC Transaction History
Simplex Trading, LLC
- $175 Billion
- Q2 2025
A detailed history of Simplex Trading, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Simplex Trading, LLC holds 667 shares of SLN stock, worth $4,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
667
Previous 251
165.74%
Holding current value
$4,148
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SLN
# of Institutions
57Shares Held
20.6MCall Options Held
22.8KPut Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$18.9 Million3.59% of portfolio
-
Siren, L.L.C. New York, NY2.91MShares$18.1 Million0.87% of portfolio
-
Redmile Group, LLC San Francisco, CA2.16MShares$13.5 Million1.53% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$11.5 Million0.9% of portfolio
-
Morgan Stanley New York, NY1.21MShares$7.54 Million0.0% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $223M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...